Evidence mapPaperPMID 42311330Full record

ReviewFrontiers in physiology2026

Skeletal muscle overuse injury: pathophysiological mechanisms, molecular pathways, and rehabilitation strategies.

Guoliang Wu, Na Li

Abstract readReview
In one paragraph

Review in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Guoliang WuGuangxi Science and Technology Normal University, Laibin, China.
Na LiGuangxi Science and Technology Normal University, Laibin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skeletal muscle overuse injury (OUI) is a load-related condition that develops when repeated mechanical loading exceeds the adaptive and reparative capacity of skeletal muscle. Unlike acute traumatic injury or delayed-onset muscle soreness after unaccustomed eccentric exercise, chronic skeletal muscle OUI is characterized by recurrent subthreshold loading, insufficient recovery, persistent low-grade inflammation, impaired regeneration, and maladaptive remodeling. This narrative review summarizes and critically appraises current evidence on the conceptual boundaries, pathophysiological mechanisms, molecular pathways, and rehabilitation strategies of skeletal muscle OUI. Particular emphasis is placed on distinguishing direct skeletal muscle evidence from indirect or extrapolative evidence derived from acute injury models, adjacent musculoskeletal disorders, disease models, or preclinical studies. Key mechanisms include myofiber microdamage, satellite-cell-mediated repair, extracellular matrix remodeling, inflammatory signaling, oxidative stress, mitochondrial dysfunction, protein turnover, and myogenic transcriptional regulation. Current management remains centered on individualized load modification, graded rehabilitation, correction of biomechanical contributors, and criteria-based return to activity. Pharmacological and physical modalities may provide adjunctive symptom control in selected cases, whereas regenerative, gene-based, wearable-sensor-based, and artificial-intelligence-assisted approaches remain emerging or experimental for chronic skeletal muscle OUI. By integrating mechanistic evidence with rehabilitation practice and evidence appraisal, this review provides a focused framework for understanding, preventing, and managing skeletal muscle OUI.

Indexed as

evidence hierarchyextracellular matrix remodelinginflammationload managementmitochondrial dysfunctionoxidative stressrehabilitationsatellite cells

Identifiers

PMID42311330
PMCPMC13268950

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.